Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?

Clinical Endocrinology

Volumn 61, Issue 1, 2004, Pages 102-108

  Taieb D ^a   Sebag, F ^a   Hubbard, J G ^a   Mundler, O ^a   Henry, J F ^a   Conte Devolx, B ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; METADRENALIN; TRACER;

ADOLESCENT; ADULT; ARTICLE; CERVICAL SPINAL CORD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FEMALE; GENETIC DISORDER; HEREDITARY PHEOCHROMOCYTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCHOOL CHILD; SCINTIGRAPHY; SPORADIC PHEOCHROMOCYTOMA; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; URINALYSIS; VON HIPPEL LINDAU DISEASE;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADULT; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METANEPHRINE; MIDDLE AGED; PHEOCHROMOCYTOMA; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3242736405     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02077.x     Document Type: Article

References (38)

1. Baghai, M., Thompson, G.B., Young, W.F. Jr, Grant, C.S., Michels, V.V. & van Heerden, J.A. (2002) Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Archives of Surgery, 137, 682-689.
2. Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Gregianin, M. & Macri, C. (1998) Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. Journal of Clinical Endocrinology and Metabolism, 83, 55-62.
3. Bomanji, J., Levison, D.A., Flatman, W.D., Horne, T., Bouloux, P.M. & Ross, G. (1987) Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison. Journal of Nuclear Medicine, 28, 973-978.
4. Bravo, E.L. & Tagle, R. (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocrine Reviews, 24, 539-553.
5. Chatal, J.F. & Charbonnel, B. (1985) Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. Journal of Clinical Endocrinology and Metabolism, 61, 769-772.
6. De Graaf, J.S., Dullaart, R.P., Kok, T., Piers, D.A. & Zwierstra, R.P. (2000) Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. European Journal of Surgery, 166, 289-292.
7. Dluhy, R.G. (2002) Pheochromocytoma: death of an axiom. New England Journal of Medicine, 346, 1486-1488.
8. Eisenhofer, G., Lenders, J.W., Linehan, W.M., Walther, M.M., Goldstein, D.S. & Keiser, H.R. (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New England Journal of Medicine, 340, 1872-1879.
9. Eisenhofer, G., Walther, M.M., Huynh, T.T., Li, S.T., Bornstein, S.R. & Vortmeyer, A. (2001) Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. Journal of Clinical Endocrinology and Metabolism, 86, 1999-2008.
10. Erickson, D., Kudva, Y.C., Ebersold, M.J., Thompson, G.B., Grant, C.S. & van Heerden, J.A. (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. Journal of Clinical Endocrinology and Metabolism, 86, 5210-5216.
11. Gagner, M., Lacroix, A. & Bolte, E. (1992) Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. New England Journal of Medicine, 327, 1033.
12. Gagner, M., Pomp, A., Heniford, B.T., Pharand, D. & Lacroix, A. (1997) Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Annals of Surgery, 226, 238-246.
13. Gimenez-Roqueplo, A.P., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Khau Van Kien, P., Corvol, P., Plouin, P.F., Jeunemaitre, X. & COMETE Network (2003) Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Research, 63, 5615-5621.
14. 131I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. Journal of Nuclear Medicine, 42, 993-997.
15. Hoegerle, S., Nitzsche, E., Altehoefer, C., Ghanem, N., Manz, T. & Brink, I. (2002) Pheochromocytomas: detection with 18F DOPA whole body PET - initial results. Radiology, 222, 507-512.
16. Jalil, N.D., Pattou, F.N., Combemale, F., Chapuis, Y., Henry, J.F. & Peix, J.L. (1998) Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). European Journal of Surgery, 164, 23-28.
17. Kopf, D., Bockisch, A., Steinert, H., Hahn, K., Beyer, J. & Neumann, H.P. (1997) Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma. Clinical Endocrinology (Oxford), 46, 39-44.
18. Lenders, J.W., Pacak, K., Walther, M.M., Linehan, W.M., Mannelli, M. & Friberg, P. (2002) Biochemical diagnosis of pheochromocytoma: which test is best? Journal of the American Medical Association, 287, 1427-1434.
19. Mannelli, M., Ianni, L., Cilotti, A. & Conti, A. (1999) Pheochromocytoma in Italy: a multicentric retrospective study. European Journal of Endocrinology, 141, 619-624.
20. Maurea, S., Klain, M., Mainolfi, C., Ziviello, M. & Salvatore, M. (2001) The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. Journal of Nuclear Medicine, 42, 884-892.
21. Maurea, S., Lastoria, S., Caraco, C., Klain, M., Varrella, P. & Acampa, W. (1996) The role of radiolabeled somatostatin analogs in adrenal imaging. Nuclear Medicine and Biology, 23, 677-680.
22. Mihai, R., Wong, N.A., Luckett, M., Sheffield, E. & Farndon, J.R. (1998) No correlation between phaeochromocytoma catecholamine secretion and granule ultrastructure. British Journal of Surgery, 85, 1681-1685.
23. Miskulin, J., Shulkin, B.L., Doherty, G.M., Sisson, J.C., Burney, R.E. & Gauger, P.G. (2003) Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery, 134, 918-922.
24. Mozley, P.D., Kim, C.K., Mohsin, J., Jatlow, A., Gosfield, E. 3rd & Alavi, A. (1994) The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. Journal of Nuclear Medicine, 35, 1138-1144.
25. Neumann, H.P., Berger, D.P., Sigmund, G., Blum, U., Schmidt, D. & Parmer, R.J. (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. New England Journal of Medicine, 329, 1531-1538.
26. Neumann, H.P., Bausch, B., McWhinney, S.R., Bender, B.U., Gimm, O. & Franke, G. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine, 346, 1459-1466.
27. 131I MIBG uptake in phaeochromocytoma and paraganglioma. Australian and New Zealand Journal of Surgery, 69, 350-353.
28. Pacak, K., Eisenhofer, G., Carrasquillo, J.A., Chen, C.C., Li, S.T. & Goldstein. D.S. (2001) 6[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension, 38, 6-8.
29. Remine, W.H., Chong, G.C., Van Heerden, J.A., Sheps, S.G. & Harrison, E.G. Jr (1974) Current management of pheochromocytoma. Annals of Surgery, 179, 740-748.
30. Sawka, A.M., Jaeschke, R., Singh, R.J. & Young, W.F. (2003) A comparison of biochemical tests for pheochromocytome: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. Journal of Clinical Endocrinology and Metabolism, 88, 553-558.
31. Shapiro, B., Copp. J.E., Sisson, J.C., Eyre, P.L., Wallis, J. & Beierwaltes, W.H. (1985) Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. Journal of Nuclear Medicine, 26, 576-585.
32. Shulkin, B.L., Wieland, D.M., Schwaiger, M., Thompson, N.W., Francis, I.R. & Haka, M.S. (1992) PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. Journal of Nuclear Medicine, 33, 1125-1131.
33. Shulkin, B.L., Koeppe, R.A., Francis, I.R., Deeb, G.M., Lloyd, R.V. & Thompson, N.W. (1993) Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology, 186, 711-715.
34. Shulkin, B.L., Thompson, N.W., Shapiro, B., Francis, I.R. & Sisson, J.C. (1999) Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D- glucose PET. Radiology, 212, 35-41.
35. Tenenbaum, F., Lumbroso, J., Schlumberger, M., Mure, A., Plouin, P.F. & Caillou, B. (1995) Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MTBG) scintigraphy in malignant pheochromocytoma. Journal of Nuclear Medicine, 36, 1-6.
36. Thompson, G.B., Grant, C.S., van Heerden, J.A., Schlinkert, R.T., Young, W.F. Jr & Farley, D.R. (1997) Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery, 122, 1132-1136.
37. Van der Harst, E., de Herder, W.W., Bruining, H.A., Bonjer, H.J., de Krijger, R.R. & Lamberts, S.W. (2001) [123I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. Journal of Clinical Endocrinology and Metabolism, 86, 685-693.
38. Van Heerden, J.A., Sheps, S.G., Hamberger, B., Sheedy, P.F. 2nd, Poston, J.G. & Remine, W.H. (1982) Pheochromocytoma: current status and changing trends. Surgery, 91, 367-373.